Prurigo Nodularis Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027
Prurigo Nodularis Treatment Market size was valued at more than USD 1 billion in 2020 and is estimated to grow at over 5% CAGR between 2021 and 2027.
Prurigo nodularis is classified as a skin condition in which hard, itchy nodules or lumps form on the surface of the skin. This rare and chronic inflammatory disease can appear on the arms, lower limbs, shoulders, buttocks, and other parts of the body. Prurigo Nodularis is more common in adults between the ages of 20 and 60, especially in adults with HIV and atopic dermatitis. On the other hand, the treatment adoption rate has increased significantly as awareness has increased due to the growth of the nodular pruritus treatment market.
Market Segments
By Product
- Antihistamines
- Capsaicin Cream
- Corticosteroids
- Emollients
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Key Players
Some of the key market players are Bayer AG, Pfizer Inc., GlaxoSmithKline Plc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services, Inc., Merck & Co. Inc., Sanofi SA, Takeda Pharmaceutical Company Limited, Novartis AG, Celgene Corporation, Galderma SA (Nestle Skin Health Company), VYNE Therapeutics Inc., Trevi Therapeutics Inc.
Scope of the Report
The research study analyzes the global Prurigo Nodularis Treatment industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Prurigo Nodularis Treatment Market Report
1. What was the Prurigo Nodularis Treatment Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).
2. What will be the CAGR of the Prurigo Nodularis Treatment Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Prurigo Nodularis Treatment Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report will be delivered within 48-72 hours after payment confirmation